Private Advisor Group LLC Acquires 3,584 Shares of Crocs, Inc. (NASDAQ:CROX)

Private Advisor Group LLC lifted its holdings in Crocs, Inc. (NASDAQ:CROXFree Report) by 23.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,044 shares of the textile maker’s stock after acquiring an additional 3,584 shares during the period. Private Advisor Group LLC’s holdings in Crocs were worth $2,758,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CROX. GHP Investment Advisors Inc. lifted its stake in shares of Crocs by 375.0% in the 2nd quarter. GHP Investment Advisors Inc. now owns 228 shares of the textile maker’s stock valued at $33,000 after purchasing an additional 180 shares during the last quarter. UMB Bank n.a. boosted its stake in Crocs by 64.9% during the third quarter. UMB Bank n.a. now owns 305 shares of the textile maker’s stock worth $44,000 after buying an additional 120 shares during the period. V Square Quantitative Management LLC boosted its stake in Crocs by 83.0% during the third quarter. V Square Quantitative Management LLC now owns 313 shares of the textile maker’s stock worth $45,000 after buying an additional 142 shares during the period. Blue Trust Inc. raised its stake in shares of Crocs by 19.3% in the second quarter. Blue Trust Inc. now owns 1,001 shares of the textile maker’s stock valued at $144,000 after acquiring an additional 162 shares during the period. Finally, Nisa Investment Advisors LLC raised its stake in shares of Crocs by 8.9% in the second quarter. Nisa Investment Advisors LLC now owns 1,041 shares of the textile maker’s stock valued at $152,000 after acquiring an additional 85 shares during the period. Hedge funds and other institutional investors own 93.44% of the company’s stock.

Insider Buying and Selling at Crocs

In other news, Director John B. Replogle acquired 1,996 shares of Crocs stock in a transaction that occurred on Friday, August 2nd. The stock was purchased at an average price of $123.96 per share, for a total transaction of $247,424.16. Following the purchase, the director now directly owns 7,064 shares in the company, valued at $875,653.44. The trade was a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, Director Douglas J. Treff sold 10,594 shares of the firm’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $132.38, for a total value of $1,402,433.72. Following the completion of the sale, the director now owns 81,254 shares of the company’s stock, valued at $10,756,404.52. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John B. Replogle bought 1,996 shares of Crocs stock in a transaction that occurred on Friday, August 2nd. The shares were acquired at an average cost of $123.96 per share, for a total transaction of $247,424.16. Following the completion of the transaction, the director now directly owns 7,064 shares in the company, valued at $875,653.44. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 2.72% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on CROX. Piper Sandler reiterated an “overweight” rating and set a $170.00 price target on shares of Crocs in a report on Friday, August 23rd. KeyCorp raised their price target on Crocs from $149.00 to $155.00 and gave the stock an “overweight” rating in a research note on Thursday, September 26th. Guggenheim assumed coverage on Crocs in a report on Wednesday, October 9th. They set a “buy” rating and a $182.00 price objective for the company. Barclays reduced their target price on Crocs from $169.00 to $164.00 and set an “overweight” rating on the stock in a research note on Friday, August 2nd. Finally, UBS Group lowered their target price on shares of Crocs from $148.00 to $146.00 and set a “neutral” rating for the company in a research note on Tuesday, July 16th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, Crocs has a consensus rating of “Moderate Buy” and a consensus target price of $162.58.

Check Out Our Latest Stock Report on Crocs

Crocs Stock Performance

Shares of CROX stock opened at $138.05 on Tuesday. The company’s 50 day moving average is $138.15 and its 200 day moving average is $138.75. The company has a quick ratio of 0.95, a current ratio of 1.50 and a debt-to-equity ratio of 0.93. The firm has a market cap of $8.38 billion, a price-to-earnings ratio of 10.68, a PEG ratio of 1.35 and a beta of 1.99. Crocs, Inc. has a 52-week low of $74.00 and a 52-week high of $165.32.

Crocs (NASDAQ:CROXGet Free Report) last released its quarterly earnings results on Thursday, August 1st. The textile maker reported $4.01 EPS for the quarter, topping the consensus estimate of $3.59 by $0.42. Crocs had a return on equity of 53.20% and a net margin of 20.02%. The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same period in the previous year, the company posted $3.59 EPS. The business’s revenue for the quarter was up 3.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Crocs, Inc. will post 12.88 EPS for the current fiscal year.

Crocs Company Profile

(Free Report)

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.

Recommended Stories

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.